Precision BioSciences Inc
NASDAQ:DTIL

Watchlist Manager
Precision BioSciences Inc Logo
Precision BioSciences Inc
NASDAQ:DTIL
Watchlist
Price: 4.9 USD -2.58%
Market Cap: 51.7m USD

Wall Street
Price Targets

DTIL Price Targets Summary
Precision BioSciences Inc

Wall Street analysts forecast DTIL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DTIL is 21.93 USD with a low forecast of 13.13 USD and a high forecast of 31.5 USD.

Lowest
Price Target
13.13 USD
168% Upside
Average
Price Target
21.93 USD
348% Upside
Highest
Price Target
31.5 USD
543% Upside
Precision BioSciences Inc Competitors:
Price Targets
87S
Roivant Sciences Ltd
60% Upside
PRQR
ProQR Therapeutics NV
388% Upside
IMNM
Immunome Inc
165% Upside
CPRX
Catalyst Pharmaceuticals Inc
46% Upside
TNG
Transgene SA
74% Upside
005690
Pharmicell Co Ltd
49% Upside
ALT
Altimmune Inc
222% Upside
BRNS
Barinthus Biotherapeutics PLC
408% Upside

Revenue
Forecast

Revenue Estimate
Precision BioSciences Inc

For the last 7 years the compound annual growth rate for Precision BioSciences Inc's revenue is 40%. The projected CAGR for the next 3 years is -23%.

40%
Past Growth
-23%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Precision BioSciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Precision BioSciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-78%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DTIL's stock price target?
Price Target
21.93 USD

According to Wall Street analysts, the average 1-year price target for DTIL is 21.93 USD with a low forecast of 13.13 USD and a high forecast of 31.5 USD.

What is Precision BioSciences Inc's Revenue forecast?
Projected CAGR
-23%

For the last 7 years the compound annual growth rate for Precision BioSciences Inc's revenue is 40%. The projected CAGR for the next 3 years is -23%.

Back to Top